エピソード

  • 71-80 Round-Up

    71-80 Round-Up
    2026/08/24
    71-80 Round-Up Quick summaries of our last 10 articles, for busy people. 71. Buprenorphine and Dental Problems 72. Symptom-Triggered Alcohol Withdrawal Management Over Telemedicine 73. Long-Term Opioid Use After a First Prescription 74. Quick-Start Injectable Buprenorphine 75. Contingency Management for Stimulant Use Disorder and Mortality 76. Injectable Buprenorphine in Pregnancy 77. Epic’s Opioid Risk Score 78. Treating Alcohol Use Disorder in Patients with Severe Liver Disease 79. Direct-to-Inject Buprenorphine 80. Phenobarbital for Alcohol Withdrawal Full citations, for those who love references: Tuan WJ, Clebak KT, Jawadi E, Snyder J, Zgierska AE. Risk of Oral Health Problems in Adults With Opioid Use Disorder Treated With Transmucosal Buprenorphine. J Addict Med. 2025 Sep-Oct 01;19(5):529-535. doi: 10.1097/ADM.0000000000001453. Epub 2025 Mar 10. PMID: 40062592. Sloan ME, Ngoy A, Xiao KB, Barker B, Buckley L, Fodor M, Hardy K, Hendershot CS, Kahan M, La Fleur S, Le Foll B, Manicone M, Sanches M, Simpkin E, Quilty LC, Wyman J, Tang VM, Bozinoff N. Symptom-Triggered Alcohol Withdrawal Management Delivered Over Telemedicine. J Addict Med. 2025 Nov-Dec 01;19(6):708-715. doi: 10.1097/ADM.0000000000001491. Epub 2025 May 1. PMID: 40310714; PMCID: PMC12352377. Smith AM, Shah A, Martin BC. An updated view on the influence of initial opioid prescription characteristics on long-term opioid use among opioid naïve patients. Drug Alcohol Depend. 2024 Dec 1;265:112463. doi: 10.1016/j.drugalcdep.2024.112463. Epub 2024 Oct 24. PMID: 39549364; PMCID: PMC11924105. Shiwach R, Le Foll B, Alho H, Dunn KE, Strafford S, Zhao Y, Dobbins RL. Rapid vs Standard Induction to Injectable Extended-Release Buprenorphine: A Randomized Clinical Trial. JAMA Netw Open. 2025 Oct 1;8(10):e2537319. doi: 10.1001/jamanetworkopen.2025.37319. PMID: 41085986; PMCID: PMC12522003. Coughlin LN, Tomlinson DC, Zhang L, Kim HM, Frost MC, Khazanov G, McKay JR, DePhilippis D, Lin LA. Contingency Management for Stimulant Use Disorder and Association With Mortality: A Cohort Study. Am J Psychiatry. 2025 Nov 1;182(11):1016-1023. doi: 10.1176/appi.ajp.20250053. Epub 2025 Sep 10. PMID: 40926572. Winhusen TJ, Lofwall MR, Kropp F, Lewis D, Smid MC, Young JL, Hodgkins C, Krans EE, Hansen Z, Wachman EM, Schiff DM, Guille C, Rudolf V, Chowdhury T, Leeman L, Lewis M, Matthews AG, Cochran G, King J, Wilder C, Rosa C. Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical Trial. JAMA Intern Med. 2026 May 1;186(5):533-543. doi: 10.1001/jamainternmed.2026.0057. Hooker SA, Rossom RC, Haapala J, Crain AL, Miley K, Olson AW, Kane S, Christensen K, O'Connor PJ, Bart G, Wright EA. External Validation of Epic's Risk of Opioid Abuse and Overdose Model Among Primary Care Patients in Three Health Systems. J Gen Intern Med. 2026 Feb 17. doi: 10.1007/s11606-026-10257-1. Epub ahead of print. PMID: 41703383. Sundaresh R, Singh J, Meza J, Saab S, Shetty A. Medications for Alcohol Use Disorder Among Patients With Severe Alcohol-Related Liver Disease. JAMA Netw Open. 2026 Feb 2;9(2):e2559016. doi: 10.1001/jamanetworkopen.2025.59016. PMID: 41670995; PMCID: PMC12895287. Rosenwohl-Mack S, Heeney M, Samuel L, Anderson E, Herring AA, Sirey LR, Peterson D, Bazazi AR, Snyder H, Suen LW. Outpatient initiation of direct-to-inject buprenorphine. Drug Alcohol Depend. 2026 Jan 1;278:113011. doi: 10.1016/j.drugalcdep.2025.113011. Epub 2025 Dec 19. PMID: 41442975; PMCID: PMC13271074. Wolpaw BJ, Oren H, Quinnan-Hostein L, Bradley KA, Johnson NJ, Hallgren KA, Gupta A, Kim HN, Granich MA, Steel TL. Hospital-Wide Implementation, Clinical Outcomes, and Safety of Phenobarbital for Alcohol Withdrawal. JAMA Netw Open. 2025 Aug 1;8(8):e2528694. doi: 10.1001/jamanetworkopen.2025.28694. PMID: 40853658; PMCID: PMC12379078. --- This episode does not offer CME, but others do. You can get category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. Go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES. CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/ --- Original theme music: composed and performed by Benjamin Kennedy Audio editing: Michael Bonanno Executive producer: Dr. Patrick Beeman A podcast from Ars Longa Media --- This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice. The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group. --- Email: addictionmedicinejournalclub@gmail.com Facebook: @AddictionMedJC Facebook Group: Addiction ...
    続きを読む 一部表示
    53 分
  • 81. Mirtazapine for Methamphetamine Use Disorder

    81. Mirtazapine for Methamphetamine Use Disorder
    2026/08/10
    In episode 81 we discuss using mirtazapine to treat methamphetamine use disorder. McKetin R, Shoptaw S, Saunders L, et al. Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2026;83(6):581–589. doi:10.1001/jamapsychiatry.2026.0159 We also discuss behavioral treatments added to buprenorphine, and how the FDA is promoting flavored nicotine products. JAMA Network Open: Adjunctive Psychosocial Interventions and Opioid Abstinence Among Patients Receiving Buprenorphine NBC News: Some ZYN nicotine pouches can be sold as safer than cigarettes, FDA says --- This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES. CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/ --- Original theme music: composed and performed by Benjamin Kennedy Audio editing: Michael Bonanno Executive producer: Dr. Patrick Beeman A podcast from Ars Longa Media --- This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice. The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group. --- Email: addictionmedicinejournalclub@gmail.com Facebook: @AddictionMedJC Facebook Group: Addiction Medicine Journal Club Instagram: @AddictionMedJC Threads: @AddictionMedJC YouTube: addictionmedicinejournalclub Twitter/X: @AddictionMedJC --- Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    32 分
  • 80. Phenobarbital for Alcohol Withdrawal

    80. Phenobarbital for Alcohol Withdrawal
    2026/07/27
    In episode 80 we discuss phenobarbital for alcohol withdrawal in the hospital. Wolpaw BJ, Oren H, Quinnan-Hostein L, Et al. Hospital-Wide Implementation, Clinical Outcomes, and Safety of Phenobarbital for Alcohol Withdrawal. JAMA Netw Open. 2025 Aug 1;8(8):e2528694. We also discuss DEA scheduling of 7-OH (from kratom) and the Trump administration’s pro-alcohol policies. The Hill: DEA moves to ban opioid-like kratom compound 7-OH Stat News: Even with MAHA, Trump administration has gone soft on alcohol --- This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES. CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/ --- Original theme music: composed and performed by Benjamin Kennedy Audio editing: Michael Bonanno Executive producer: Dr. Patrick Beeman A podcast from Ars Longa Media --- This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice. The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group. --- Email: addictionmedicinejournalclub@gmail.com Facebook: @AddictionMedJC Facebook Group: Addiction Medicine Journal Club Instagram: @AddictionMedJC Threads: @AddictionMedJC YouTube: addictionmedicinejournalclub Twitter/X: @AddictionMedJC --- Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    38 分
  • 79. Direct-to-Inject Buprenorphine

    79. Direct-to-Inject Buprenorphine
    2026/07/13
    In episode 79 we discuss an article about starting long-acting injectable buprenorphine without a sublingual test dose. Rosenwohl-Mack S, Heeney M, Samuel L, Anderson E, Herring AA, Sirey LR, Peterson D, Bazazi AR, Snyder H, Suen LW. “Outpatient initiation of direct-to-inject buprenorphine.” Drug and alcohol dependence vol. 278 (2026): 113011. doi:10.1016/j.drugalcdep.2025.113011 We also discuss keeping up with addiction medicine news from the current administration, and an articlre commendation from one of our listeners. KFF: The independent source for health policy research, polling, and news. KFF: View the Latest: Substance Use KFF: Tracking Key Mental Health and Substance Use Policy Actions Under the Trump Administration CBS News: New White House drug abuse strategy floats wastewater testing, AI, more treatment and faith-based options Psychological Medicine: Risk factors for the development of opioid use disorder after first opioid prescription: a Swedish national study --- This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES. CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/ --- Original theme music: composed and performed by Benjamin Kennedy Audio editing: Michael Bonanno Executive producer: Dr. Patrick Beeman A podcast from Ars Longa Media --- This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice. The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group. --- Email: addictionmedicinejournalclub@gmail.com Facebook: @AddictionMedJC Facebook Group: Addiction Medicine Journal Club Instagram: @AddictionMedJC Threads: @AddictionMedJC YouTube: addictionmedicinejournalclub Twitter/X: @AddictionMedJC --- Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    32 分
  • 78. Treating Alcohol Use Disorder in Patients with Severe Liver Disease

    78. Treating Alcohol Use Disorder in Patients with Severe Liver Disease
    2026/06/29
    In episode 78 we discuss treating alcohol use disorder in patients with severe liver disease. Sundaresh R, Singh J, Meza J, Saab S, Shetty A. Medications for Alcohol Use Disorder Among Patients With Severe Alcohol-Related Liver Disease. JAMA Netw Open. 2026;9(2):e2559016. doi:10.1001/jamanetworkopen.2025.59016 We also discuss the final dissolution of Perdue Pharma. The Guardian: Purdue Pharma to be dissolved as judge approves criminal sentence in opioid case --- This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES. CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/ --- Original theme music: composed and performed by Benjamin Kennedy Audio editing: Michael Bonanno Executive producer: Dr. Patrick Beeman A podcast from Ars Longa Media --- This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice. The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group. --- Email: addictionmedicinejournalclub@gmail.com Facebook: @AddictionMedJC Facebook Group: Addiction Medicine Journal Club Instagram: @AddictionMedJC Threads: @AddictionMedJC YouTube: addictionmedicinejournalclub Twitter/X: @AddictionMedJC --- Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    33 分
  • AMJC Poster Session

    AMJC Poster Session
    2026/06/15
    We love a good poster session. This episode we are joined by Dr. Anthony Accurso to review some of our favorite posters from the American Society of Addiction Medicine’s 2026 Annual Meeting. All the Posters from ASAM 57 Posters profiled here: 12: Real-World Analysis of Buprenorphine-Precipitated Opioid Withdrawal: A Multicenter Study 38: Co-Located Bridge Clinic/Withdrawal Management Unit Reduces 30-Day Readmits Using LA-Bup Injections 55: Increased Naltrexone Prescribed for Alcohol Use After Changes to Obesity Treatment Protocol 62: Comorbidities and Mortality in Substance Use Disorder Patients With Nicotine Dependence 115: Higher Buprenorphine Doses Improve Treatment Engagement and Outcomes in Opioid Use Disorder 119: Closing the Gap: Inpatient Methadone and Telehealth OTP Enrollment 142: Naltrexone Treatment for AI Chatbot Addiction in Adolescent With ASD and ADHD --- Original theme music: composed and performed by Benjamin Kennedy Audio editing: Michael Bonanno Executive producer: Dr. Patrick Beeman A podcast from Ars Longa Media --- This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice. The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group. --- Email: addictionmedicinejournalclub@gmail.com Facebook: @AddictionMedJC Facebook Group: Addiction Medicine Journal Club Instagram: @AddictionMedJC Threads: @AddictionMedJC YouTube: addictionmedicinejournalclub Twitter/X: @AddictionMedJC --- Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    1 時間 4 分
  • 77. Epic’s Opioid Risk Score

    77. Epic’s Opioid Risk Score
    2026/06/01
    Finally, an external validation of Epic’s controversial risk of opioid abuse and overdose model. Hooker, S.A., Rossom, R.C., Haapala, J. et al. External Validation of Epic’s Risk of Opioid Abuse and Overdose Model Among Primary Care Patients in Three Health Systems. J GEN INTERN MED (2026). We also discuss financial consequences of online sports betting, and Trump’s initiative to encourage psychedelic therapy. The Financial Consequences of Legalized Sports Gambling BMJ: Online gambling requires greater government regulation Reuters: Trump signs order to accelerate access to psychedelic drug treatments --- This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES. CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/ --- Original theme music: composed and performed by Benjamin Kennedy Audio editing: Michael Bonanno Executive producer: Dr. Patrick Beeman A podcast from Ars Longa Media --- This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice. The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group. --- Email: addictionmedicinejournalclub@gmail.com Facebook: @AddictionMedJC Facebook Group: Addiction Medicine Journal Club Instagram: @AddictionMedJC Threads: @AddictionMedJC YouTube: addictionmedicinejournalclub Twitter/X: @AddictionMedJC --- Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    37 分
  • 76. Injectable Buprenorphine in Pregnancy

    76. Injectable Buprenorphine in Pregnancy
    2026/05/18
    A new randomized controlled trial of injectable buprenorphine in pregnancy. Winhusen TJ, Lofwall MR, Kropp F, et al. Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical Trial. JAMA Intern Med. Published online March 16, 2026. We also discuss the kindling effect in opioid withdrawal, and how insurance changes can destabilize patients in recovery. Psychopharmacology: Repeated fentanyl abstinence intensifies opioid withdrawal and induces a proinflammatory state in striatal microglia STAT: How the insurance system quietly undoes recovery from addiction --- This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES. CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/ --- Original theme music: composed and performed by Benjamin Kennedy Audio editing: Michael Bonanno Executive producer: Dr. Patrick Beeman A podcast from Ars Longa Media --- This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice. The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group. --- Email: addictionmedicinejournalclub@gmail.com Facebook: @AddictionMedJC Facebook Group: Addiction Medicine Journal Club Instagram: @AddictionMedJC Threads: @AddictionMedJC YouTube: addictionmedicinejournalclub Twitter/X: @AddictionMedJC --- Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    41 分